2 weeks Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030 24/7 Wall St.

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor and the transformative COVID-19 vaccine Comirnaty, developed with BioNTech (NASDAQ:BNTX), Pfizer has shaped healthcare for decades. Its $43 billion acquisition of Seagen in 2023 […]

The post Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030 appeared first on 24/7 Wall St..

       

The Stock Market News

The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live qoute and chart technical analysis, opinion, price forecast on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.